Home > Quotes > LGND > Press Releases
LGND

Ligand Pharmaceuticals Incorporated Press Releases

$32.54
*  
1.11
  negative  
3.53%
Get LGND Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LGND Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Ligand Provides New Corporate Presentation at Investor Conference
05/29/2013 8:30AM - Business Wire

Ligand to Present at Upcoming Investor Conferences
05/23/2013 8:30AM - Business Wire

Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV
05/14/2013 8:30AM - Business Wire

Ligand Reports First Quarter Financial Results
05/08/2013 4:00PM - Business Wire

Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
04/30/2013 5:50AM - PR Newswire

Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA
04/30/2013 5:50AM - Business Wire

Ligand Presents Preclinical Data on HepDirect™ Liver-Targeting Technology Platform at 2013 International Liver Congress (EASL) Annual Meeting
04/26/2013 8:30AM - Business Wire

Ligand to Present at Upcoming Investor Conferences
04/23/2013 9:00AM - Business Wire

Ligand to Report First Quarter Results on May 8th
04/22/2013 9:00AM - Business Wire